DPB Antibiotics Private Limited
Anchoring the international healthcare network with continuous multi-scale chemical synthesis and high-volume, absolute-purity sterile active pharmaceutical ingredients.
Explore Global Operations
Global Manufacturing Agility & Industrial Legacy
Rooted firmly in the substantial industrial scale and technical excellence of Vardhman Chemtech Limited (VCL) established in 2005, our entire ecosystem has synchronized operations under the global corporate entity of DPB Antibiotics Private Limited.
This calculated alignment enhances our end-to-end supply chain responsiveness, accelerates multi-country regulatory clearances, and guarantees uninterrupted volume metrics for life-saving therapeutics worldwide.
Advanced Production Infrastructure
01 / High-Velocity Scale
Processing advanced configurations with an operational capability of 720 MT per annum dedicated to the core Isoxazoles compounds segment.
Technical Assets
02 / Advanced Instrumentation
Operating 2 premium plant complexes running over 60 automated reactors, validated continuously via 3 independent control testing laboratories.
Facility Details
03 / Global Supply Authority
Positioned internationally as one of only two completely integrated Isoxazole systems worldwide, exporting reliably to over 50+ countries.
Logistics Blueprint720 MT
Isoxazoles Cap
400 MT
Enzymatic Output
60+
High-Scale Reactors
50+
Export Sovereign Nations
Active Pharmaceutical Ingredients (APIs)
High-purity specialized therapeutic categories manufactured under absolute quality compliance standards: